|
1
|
Krebs-Brown A, Munafo A, Gaikwad S, Urgatz B, Castello-Bridoux C. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?". Clin Pharmacokinet 2019; 59:265-267. [PMID: 31802400 PMCID: PMC7007443 DOI: 10.1007/s40262-019-00847-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
| | - Alain Munafo
- Merck Institute for Pharmacometrics (An Affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland
| | | | | | - Claire Castello-Bridoux
- Direction des Affaires Médicales, Merck Santé s.a.s, 37 rue Saint-Romain, 69008, Lyon, France.
| |
Collapse
|
|
2
|
Concordet D, Gandia P, Montastruc JL, Bousquet-Mélou A, Lees P, Ferran AA, Toutain PL. Authors' Reply to Lechat et al.: "Levothyrox ® New and Old Formulations: Are they Switchable for Millions of Patients?". Clin Pharmacokinet 2019; 58:1353-1354. [PMID: 31452151 PMCID: PMC6768902 DOI: 10.1007/s40262-019-00815-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
| | - Peggy Gandia
- INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France
| | - Jean-Louis Montastruc
- Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse, Toulouse, France
| | | | - Peter Lees
- The Royal Veterinary College, University of London, London, UK
| | - Aude A Ferran
- INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France
| | - Pierre-Louis Toutain
- INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France. .,The Royal Veterinary College, University of London, London, UK.
| |
Collapse
|